Related Experiment Video
Updated: Aug 2, 2025
12:20
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
21.2K
Provider-directed analgesia for dental pain.
Alan L Myers1, Arthur H Jeske2
1Department of Diagnostic & Biomedical Sciences, School of Dentistry, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Expert Review of Clinical Pharmacology
|April 21, 2023
Summary
Managing dental pain after molar extraction effectively is crucial. Combining NSAIDs with acetaminophen offers superior relief, while short-term opioids and alternative agents can be used judiciously for severe pain.
Area of Science:
- Dental pharmacology and pain management.
- Evidence-based review of analgesic therapies.
- Provider-directed analgesic (PDA) strategies in dentistry.
Background:
- Postoperative pain following impacted molar extraction is a common and significant concern.
- Effective pain management is essential to prevent oral and systemic health complications.
- The opioid epidemic necessitates a shift towards safer analgesic approaches in dental practice.
Approach:
- Comprehensive review of established and alternative analgesic agents for dental pain.
- Analysis of pharmacological and therapeutic properties of various pain relievers.
- Evaluation of evidence supporting combination therapies and preemptive strategies.
Key Points:
- Combination of non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen provides superior pain relief compared to opioids.
- Short-course opioid prescriptions (2-3 days) may be appropriate for select patients with severe pain.
- Alternative agents like caffeine, gabapentin, and phytotherapies can supplement established treatments.
- Preemptive therapies, including corticosteroids and NSAIDs, may reduce overall analgesic consumption.
Conclusions:
- Optimal pharmacotherapy for acute postsurgical dental pain involves a multimodal approach.
- Provider-directed analgesic (PDA) strategies should prioritize non-opioid and combination therapies.
- Understanding the evolving landscape of dental pain management is key to informed clinical practice.
Related Concept Videos
01:25Analgesia and Pain Management
689
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
689
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
464
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
464
01:24Parenteral Anesthetics: Overview
170
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
170
01:23Local Anesthetics: Common Agents and Their Applications
494
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
494
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
358
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
358
01:11Local Anesthetics: Clinical Application as Spinal Anesthesia
691
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
691